Parkinson's Disease and Parkinsonism Clinical Trial
Official title:
Correlation of Diaphragmatic Thickness With Pulmonary Function in Parkinson's Disease
Ultrasound can give important information about the morphology of the diaphragm and the amount of contraction. Our aim, with the prediction that a restrictive pathology will occur in the pulmonary function with the addition of camptocormia in Parkinson's patients; to compare respiratory functions in Parkinson's patients with and without camptocormia, to investigate the correlation between ultrasonographically measured diaphragmatic thickness and pulmonary function test values.
Respiratory complications are one of the most common causes of death in Parkinson's patients. In Parkinson's disease, abnormal flexion of the thoracolumbar spine of 45° or more, which is called camptocormia, increases during walking or standing and disappears completely in the supine position. The prevalence of camptocormia among Parkinson's patients is about 7%. Camptocormia in Parkinson's disease is associated with significant disease disability, higher daily dopaminergic drug dosage, and cognitive impairment. Parkinson's patients with camptocormia often complain of shortness of breath, attributed to reduced pulmonary capacity due to limited chest expansion. Diaphragmatic dyskinesia in Parkinson's patients may also lead to a restrictive deterioration in respiratory functions. Diaphragmatic thickness indicates diaphragmatic contraction and is correlated with PFT. Our aim; It is a comparison of respiratory functions in Parkinson's patients with and without camptocormia. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06037590 -
A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops™ Relative to INBRIJA®
|
Phase 1 | |
| Enrolling by invitation |
NCT04799418 -
STEM-PD Open Label Extension (OLE)
|
N/A | |
| Not yet recruiting |
NCT06074393 -
Caregiving in Advanced PD: A Tailored Support Group
|
N/A | |
| Completed |
NCT05699161 -
Adipose-derived Stromal Vascular Fraction Cells to Treat Parkinson
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05599659 -
The Calgary Movement Disorders Advanced Care Pilot Program
|
N/A | |
| Completed |
NCT04140708 -
Effects of Exercise on Glymphatic Functioning and Neurobehavioral Correlates in Parkinson's Disease
|
N/A | |
| Recruiting |
NCT03924414 -
Trial of Parkinson's And Zoledronic Acid
|
Phase 4 | |
| Recruiting |
NCT06203106 -
NYSCF Scientific Discovery Biobank
|
||
| Not yet recruiting |
NCT06400017 -
Mechanism and Application of DBS in the Treatment of PD
|
N/A | |
| Recruiting |
NCT04797611 -
STEM-Parkinson's Disease
|
N/A | |
| Not yet recruiting |
NCT06174948 -
The Use of the CUE1 in People With Parkinson's Disease and Related Disorders
|
N/A | |
| Recruiting |
NCT05934747 -
Aim 3 Particle Swarm Optimization PIGD
|
N/A | |
| Enrolling by invitation |
NCT04701177 -
Digitally-enhanced, Decentralized, Multi-omics Observational Cohort
|
||
| Recruiting |
NCT05962489 -
Sleep-specific DBS Therapy in Parkinson's Disease
|
N/A | |
| Recruiting |
NCT05931692 -
Virtual Reality and Fear of Falling in Parkinson's Disease
|
||
| Recruiting |
NCT04468919 -
Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit
|
N/A | |
| Completed |
NCT04925622 -
Complex Eye Movements in Parkinson's Disease and Related Movement Disorders
|
||
| Recruiting |
NCT04214509 -
LIPAD - LRRK2 International Parkinson's Disease Study
|
||
| Active, not recruiting |
NCT05677633 -
Biomarker Validation Following Sargramostim Treatment in Parkinson's Disease
|
Phase 1 | |
| Recruiting |
NCT06350617 -
Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients
|
N/A |